Compositions And Methods For Diagnosing And Treating Community-acquired Methicillin-resistant Staphylococcus Aureus

Abstract

The present invention includes compositions and methods for diagnosing and treating CA-MRSA infections in patients. The methods are based on the finding that combining cefoxitin and a synthetic penicillin in a treatment regimen results in a synergistic effect of the two drugs, an effect that is related to PBP4 activity in CA-MRSA isolates. Also provided is a CA-MRSA-specific biomarker which can be used to detect the presence of a CA-MRSA infection in a patient.


Claims
Download PDF
Document Preview
Document History
  • Publication: Aug 30, 2016
  • Application: Aug 7, 2008
    US US 67045708 A
  • Priority: Aug 7, 2008
    US US 67045708 A
  • Priority: Aug 7, 2008
    US US 2008/0072442 W
  • Priority: Aug 22, 2007
    US US 95731407 P

Download Citation


Sign in to the Lens

Feedback